RSS Feeds
Search

Articles

Pharmalicensing brings you advice, commentary and analysis from industry experts.

Articles

No results found for given criteria.
Please try to put more general criteria into your selection.

Related Reports

Market Research Reports provided by reports.iptechex.com
Stakeholder Insight: Acute Leukemias - Reaching the limits of cytotoxic chemotherapy
Oct 2009 - 199 pages - $15,200
Leukemia and Types of Leukemia Therapy Area Pipeline Report
Nov 2010 - 1302 pages - $1,495
The Cancer and Leukemia Group B – Developmental Therapeutics Review – Q4 2010
Nov 2010 - 40 pages - $500
Acute Myelocytic Leukemia (AML) - Pipeline Review, H2 2011
Sep 2011 - 370 pages - $500
T-Cell Leukemia - Pipeline Review, Q1 2011
Jan 2011 - 20 pages - $500
Epigenetics Therapeutics to 2017 – High Market Potential for Epigenetics Drugs in Acute Myeloid Leukemia, Multiple Myeloma and Cutaneous T-Cell Lymphoma
Sep 2010 - 89 pages - $3,500
Sunesis Pharmaceuticals, Inc. - Product Pipeline Review - Q4 2010
Nov 2010 - 79 pages - $500
Acute Myelogenous Leukemia Global Clinical Trials Review, Q4, 2010
Oct 2010 - 69 pages - $1,000
Northern Italy Leukemia Group – Developmental Therapeutics Review – Q4 2010
Dec 2010 - 27 pages - $500
Acute Lymphocytic Leukemia (ALL) Clinical Trials Review Q4, 2010
Oct 2010 - 65 pages - $1,000
More Related Market Research Reports >>>

Your selection

Industry sector
Service del
Communications del
Therapeutic target
Oncology del
Leukemia del
Acute myeloid leukemia del
Year
1999 del

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us